Orbit Operations
Orbit’s Next Gen Manufacturing and Quality Control Operations makes it a leader in the development and manufacture of complex GMP Active Pharmaceutical Ingredients (APIs). Orbit’s skilled experts along with inspected and approved facilities enable us to deliver quality products that deliver healthier outcomes.
Orbit’s Operational Scale
Scalable Infrastructure
Licensed by the Cyprus Securities and Exchange Commission under licence number 138/11 in accordance with the Markets in Financial Instruments Directive.
Standardized Quality Control SOPs
We are a proud member of the Investor Compensation Fund which acts as a guarantor of last resort for our investors. IFC covers the maximum amount of 20.000 EUR for MiFID clients.
Trained and Dedicated Safety Teams
Investor’s money is kept in segregated accounts with top-tier banks that cannot be claimed by creditors or used by us. Account base currencies are available in EUR, GBP, USD, CHF and JPY.
Extensive Automation and Precision Control
Through the use of an automated transaction monitoring and risk management system, a Consulting WP client’s account will never be allowed to reach negative balance.
Continuous Innovation
Our Extreme Transparency Policy ensures that the client receives a transparent price feed, transparent liquidity, transparent historical data, transparent market information at all times.
Ongoing Audit and Inspection Review
The total value of all of the client’s open positions combined (net open position) may not surpass USD 825.000.000.
Orbit’s Manufacturing and Global Presence
